OOIR: Observatory of International Research

Papers

(The H4-Index of Psychopharmacology is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Cannabidiol: pharmacology and therapeutic targets	123
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials	98
Tripping on nothing: placebo psychedelics and contextual factors	76
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants	70
Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials	69
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis	66
A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats	48
Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review	44
A specific dietary fibre supplementation improves cognitive performance—an exploratory randomised, placebo-controlled, crossover study	43
A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania	41
Chronic mild stress paradigm as a rat model of depression: facts, artifacts, and future perspectives	41
Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial	41
Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada	40
Central norepinephrine transmission is required for stress-induced repetitive behavior in two rodent models of obsessive-compulsive disorder	40
Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review	39
Risky decision-making in individuals with substance use disorder: A meta-analysis and meta-regression review	39
Matrine alleviates neurobehavioral alterations via modulation of JNK-mediated caspase-3 and BDNF/VEGF signaling in a mouse model of burn injury	38
(R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation	36
Serotonin toxicity of serotonergic psychedelics	36
Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research	35
7,8-Dihydroxyflavone improves cognitive functions in ICV-STZ rat model of sporadic Alzheimer’s disease by reversing oxidative stress, mitochondrial dysfunction, and insulin resistance	33
The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world	32
Broadening Your Mind to Include Others: The relationship between serotonergic psychedelic experiences and maladaptive narcissism	32
Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia	32
Intermittent access cocaine self-administration produces psychomotor sensitization: effects of withdrawal, sex and cross-sensitization	32

Expectancy in placebo-controlled trials of psychedelics: if so, so what?	32
The acute effects of classic psychedelics on memory in humans	31
Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan	31
A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vulnerability to relapse	30
Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study	29
A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions	29
Modulatory effects of ayahuasca on personality structure in a traditional framework	29
Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults	29